EPISODE · Aug 25, 2025 · 53 MIN
Alzheimer's
from Demy-Colton Talks Biotech · host Demy-Colton
Alzheimer’s disease is a relentless and fatal illness, creating a profound health crisis for patients, families, and societies worldwide. Without meaningful progress, the societal costs will be staggering.Global thought leaders have set an ambitious goal: to develop a treatment that can slow the progression of Alzheimer’s by 2025. While late-stage clinical successes have been elusive over the past decade, scientific understanding of the disease has advanced dramatically, particularly in the areas of early diagnosis and disease progression. This episode explores the evolving science of Alzheimer’s, the surge in drug development targeting patients in the earliest stages, and the promise that earlier intervention could deliver better outcomes for patients.
What this episode covers
Alzheimer’s disease is a relentless and fatal illness, creating a profound health crisis for patients, families, and societies worldwide. Without meaningful progress, the societal costs will be staggering.Global thought leaders have set an ambitious goal: to develop a treatment that can slow the progression of Alzheimer’s by 2025. While late-stage clinical successes have been elusive over the past decade, scientific understanding of the disease has advanced dramatically, particularly in the areas of early diagnosis and disease progression. This episode explores the evolving science of Alzheimer’s, the surge in drug development targeting patients in the earliest stages, and the promise that earlier intervention could deliver better outcomes for patients.
NOW PLAYING
Alzheimer's
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.